For researchers already on tirzepatide who want to understand how it compares to the broader landscape, the phentermine versus GLP-1 comparison provides useful context, as does the Ozempic versus retatrutide analysis
In 2024, the home care settings and fitness/weight management facilities accounted for the largest share in the global GLP-1 agonists market
Your provider should assess medical history, contraindications, and treatment readiness before any GLP-1 initiation
Across diverse patient populations, GLP-1RA use has been associated with a reduced risk of glaucoma
Supply information based on status and shortage alerts Your personalized results report will integrate the latest information about drug supply availability so that you have actionable information to help you consider your options
In the obesity trial of 48 week-duration, percentage change in body weight from baseline after 24 weeks and 48 weeks were the primary and secondary outcomes respectively